13D Filing: Gl Partners Capital Management Ltd and Sciclone Pharmaceuticals Inc (SCLN)

Page 11 of 11

Page 11 of 11 – SEC Filing

SIGNATURE

After reasonable inquiry and to the best
of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated: June 8, 2017

GL Trade Investment Limited
By: /s/ Hu Chou Hui
Name: Hu Chou Hui
Title: Director

GL China Opportunities Fund L.P.

By: GL Capital Management GP L.P., its
General Partner

By: GL Capital Management GP Limited, its
General Partner

By: /s/ Zhenfu Li
Name: Zhenfu Li
Title: Chief Executive Officer

GL Capital Management GP L.P.

By: GL Capital Management GP Limited, its
General Partner

By: /s/ Zhenfu Li
Name: Zhenfu Li
Title: Chief Executive Officer
GL Capital Management GP Limited
By: /s/ Zhenfu Li
Name: Zhenfu Li
Title: Director
GL Partners Capital Management Limited
By: /s/ Zhenfu Li
Name: Zhenfu Li
Title: Director
Mr. Zhenfu Li
By: /s/ Zhenfu Li

[Signature Page to Schedule 13D]

Follow Sciclone Pharmaceuticals Inc (NASDAQ:SCLN)

Page 11 of 11